查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體外受精市場- 2018-2028年全球行業規模、佔有率、趨勢、機會和預測，按技術、產品、卵子捐贈者、不孕不育、不孕不育、地區和競爭細分
市場調查報告書
商品編碼
1326505

體外受精市場- 2018-2028年全球行業規模、佔有率、趨勢、機會和預測，按技術、產品、卵子捐贈者、不孕不育、不孕不育、地區和競爭細分

In-Vitro Fertilization Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technique, By Product, By Egg Donor, By Infertility, By Infertility, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 117 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

體外受精市場在 2024 年至 2028 年的預測期內將出現令人印象深刻的成長。這一成長是由於不孕率上升、體外受精技術的進步以及推遲生育趨勢的日益成長造成的。

不孕率上升

不孕率上升是預測期內體外受精（IVF）市場的主要促進因素之一。由於一系列因素，包括生活方式的改變、生育延遲以及多囊卵巢症候群 (PCOS) 等疾病的發病率增加，不孕症在世界範圍內變得越來越普遍。因此，對試管受精作為不孕不育解決方案的需求不斷成長，預計這將推動試管受精市場的成長。

隨著不孕率持續上升，越來越多的人開始尋求體外受精來解決生育問題。試管受精對於長期嘗試懷孕但未成功或患有其他疾病而無法自然受孕的夫婦特別有用。

對 IVF 服務的需求不斷成長預計將推動預測期內 IVF 市場的成長。預計這種成長在發展中國家尤其強勁，這些國家獲得試管受精服務的機會有限，但對不孕不育治療的需求很高。在這些國家，隨著越來越多的人意識到體外受精的好處以及醫療保健系統變得更加先進，體外受精服務市場預計將會成長。

此外，技術的進步使體外受精變得更加容易和負擔得起。例如，胚胎培養、冷凍保存和實驗室技術的改進都有助於提高成功率和降低成本，使體外受精更容易為更多人群所接受。這進一步增加了對試管受精服務的需求，預計將推動預測期內試管受精市場的成長。

不孕率上升預計將成為預測期內全球體外受精市場的主要驅動力。隨著越來越多的人遭受不孕不育的困擾，對體外受精服務的需求預計將會增加，特別是在獲得不孕不育治療的機會有限的發展中國家。

體外受精技術的進步

由於 IVF 技術的進步，IVF 需求有所增加。自 1978 年通過體外受精實現第一例嬰兒誕生以來，已經取得了很多成就。如今，體外受精是一項高度複雜的程序，涉及多個步驟和先進技術。

IVF 技術最重要的進步之一是植入前基因檢測 (PGT)。 PGT 允許在胚胎植入子宮之前對胚胎進行遺傳疾病篩查。 PGT可以提高IVF的成功率，降低後代遺傳性疾病的風險。

IVF 技術的另一項進步是延時成像的使用。延時成像使胚胎學家能夠即時監測胚胎的發育，提供有關其活力和品質的更詳細資訊。

除了這些進步之外，試管受精診所現在還提供一系列服務，包括卵子冷凍、精子庫和代孕。這些服務為不孕不育的夫婦提供了更多選擇，並促進了 IVF 市場的成長。

轉向延遲分娩

延遲生育的轉變是預測期內全球體外受精（IVF）市場成長的另一個因素。隨著社會和經濟因素的變化，人們選擇將孩子推遲到晚年。生育延遲與年齡相關因素導致的不孕風險增加有關，例如卵巢儲備功能下降和子宮內膜異位症等疾病發生率增加。

隨著越來越多的人選擇推遲生育，對試管嬰兒服務的需求預計將會增加。對於因年齡相關因素而苦苦掙扎的夫婦來說，體外受精已成為一種可行的選擇。試管受精治療可以幫助女性使用自己的卵子受孕，即使她們的卵巢儲備已經下降。這意味著超過自然生育窗口的女性可以懷孕。

此外，IVF技術的進步，包括改進的胚胎培養和冷凍保存技術，增加了使用IVF治療成功受孕的機會。這些進步帶來了更高的成功率和更低的成本，使想要懷孕的夫婦更容易獲得和負擔得起體外受精。

延遲分娩的轉變預計將在預測期內推動 IVF 市場的成長。預計這種成長在發展中國家尤其強勁，這些國家延遲生育的趨勢最為明顯。在這些國家，試管受精治療已成為因年齡相關因素而困擾不孕症的夫婦越來越受歡迎的選擇。

延遲分娩的轉變預計將成為預測期內全球體外受精市場的主要驅動力。隨著越來越多的人推遲生育，對試管受精服務的需求預計將會增加，特別是在已開發國家，這一趨勢最為明顯。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：服務概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術分類（ICSI IVF 與非 ICSI/傳統 IVF）
    • 按產品（IVF 培養基、ICSI 機器、IVF 培養箱、冷凍系統等）
    • 按卵子捐贈者（冷凍非捐贈者、新鮮非捐贈者、冷凍捐贈者、新鮮捐贈者）
    • 按不孕不育（男性與女性）
    • 按應用（生育診所、醫院、其他）
    • 按地區
    • 按公司分類 (2022)
  • 產品圖

第 6 章：北美體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術
    • 按產品分類
    • 通過卵子捐贈者
    • 通過不孕不育
    • 按應用
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術
    • 按產品分類
    • 通過卵子捐贈者
    • 通過不孕不育
    • 按應用
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術
    • 按產品分類
    • 通過卵子捐贈者
    • 通過不孕不育
    • 按應用
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美洲體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術
    • 按產品分類
    • 通過卵子捐贈者
    • 通過不孕不育
    • 按應用
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲體外受精市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按技術
    • 按產品分類
    • 通過卵子捐贈者
    • 通過不孕不育
    • 按應用
    • 按國家/地區
  • MEA：國家分析
    • 南非體外受精
    • 沙烏地阿拉伯體外受精
    • 阿拉伯聯合大公國體外受精
    • 土耳其體外受精

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球體外受精市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
    • The Fertility Center of Las Vegas
    • Overlake Reproductive Health
    • Gennet City Fertility
    • Zita West Clinic
    • Fertility Plus Clinic
    • Nova IVF Centre and Fertility Clinic
    • Bloom IVF Centre
    • Progenesis Fertility Center
    • Medicana IVF Center
    • Medical Park Hospitals
    • ART Fertility Clinics
    • Millennium Medical Center (MMC) IVF Fertility Center
    • Tambre Fertility Clinic
    • Medical Park Hospitals
    • Hisar Hospital

第 16 章：戰略建議

簡介目錄
Product Code: 15131

In-Vitro Fertilization Market will see impressive growth during the forecast period, 2024-2028. This growth is accounted for by increasing infertility rates, advancements in IVF technology, and a growing trend toward delaying childbirth.

In-vitro fertilization (IVF) is a medical procedure that involves fertilizing an egg with sperm outside the body in a laboratory dish and then transferring the embryo to the uterus. It is a widely used assisted reproductive technology (ART) that has helped millions of couples worldwide to conceive.

The infertility rate has been increasing globally. This is one of the key factors driving the growth of the IVF market. Several factors, including lifestyle changes, pollution, and an increase in age-related infertility, have contributed to the rising infertility rates.

Technological advancements in IVF have made the procedure safer, more effective, and less invasive. The use of preimplantation genetic testing (PGT) to screen embryos for genetic abnormalities, for example, has increased the success rates of IVF and reduced the risk of genetic disorders.

Medical tourism has emerged as a key driver of the IVF market in recent years. Patients from countries where IVF treatment is either expensive or unavailable are increasingly traveling to other countries to undergo treatment. This has helped to boost demand for IVF in countries with advanced IVF infrastructure and expertise.

The growing trend of fertility preservation, particularly among cancer patients, is driving demand for IVF services. As more people seek to preserve their fertility before undergoing treatments that could potentially harm their reproductive capacity, in such cases, IVF is becoming an increasingly important option.

A growing trend towards delaying childbirth has contributed to the growth of the IVF market. Women are now focusing on their careers and delaying pregnancy until later in life. This has led to a higher demand for IVF services, as women over the age of 35 are more likely to experience infertility.

However, with any rapidly growing industry, the IVF market faces challenges that could impact its long-term sustainability and success. One of the primary challenges the IVF market is facing is the cost of treatment. IVF is an expensive procedure, and even in countries with universal healthcare, access to IVF is often limited to those who can afford it. This has led to concerns about the affordability of IVF, particularly as demand for the treatment continues to rise.

Another challenge being faced by the IVF market is the ethical and moral considerations associated with the procedure. There are concerns that IVF could be used to create designer babies or that embryos may be discarded or used for research purposes without consent. As a result, there is a need for clear guidelines and regulations to ensure that IVF is used ethically and responsibly.

The procedure's high rate of multiple births will also impede market expansion in the coming years. To improve the probability of success, IVF frequently involves the transfer of numerous embryos, but this can lead to multiple pregnancies, which are linked to a higher risk of issues like early birth and low birth weight. To lower the probability of multiple births, more efficient embryo selection techniques are required.

Rising Infertility Rates

Rising infertility rates are one of the key drivers of the market for in-vitro fertilization (IVF) in the forecast period. Infertility is becoming more prevalent worldwide due to a range of factors, including changing lifestyles, delayed childbearing, and increasing incidence of conditions such as polycystic ovary syndrome (PCOS). As a result, there is a growing demand for IVF as a solution to infertility, which is expected to drive growth in the IVF market.

As infertility rates continue to rise, more people are turning to IVF as a solution to their fertility problems. IVF is particularly useful for couples who have been trying to conceive for a long time without success or who have other medical conditions that prevent them from conceiving naturally.

The rising demand for IVF services is expected to drive growth in the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where access to IVF services is limited, but the need for infertility treatments is high. In these countries, the market for IVF services is expected to grow as more people become aware of the benefits of IVF and as healthcare systems become more advanced.

Furthermore, advancements in technology have made IVF more accessible and affordable. For example, improvements in embryo culture, cryopreservation, and laboratory techniques have all contributed to higher success rates and lower costs, making IVF more accessible to a wider population. This has further increased the demand for IVF services and is expected to drive the growth of the IVF Market in the forecast period.

Rising infertility rates are expected to be a key driver of the global market for in-vitro fertilization in the forecast period. As more people struggle with infertility, the demand for IVF services is expected to increase, particularly in developing countries where access to infertility treatments is limited.

Advancements in IVF Technology

IVF demand has increased as an outcome of advancements in IVF technology. Since the first birth made possible by IVF in 1978, much has been accomplished. Today, IVF is a highly sophisticated procedure that involves multiple steps and advanced technologies.

One of the most significant advances in IVF technology is Preimplantation Genetic Testing (PGT). PGT allows embryos to be screened for genetic disorders before they are implanted into the uterus. PGT can improve the success rates of IVF and reduce the risk of genetic disorders in offspring.

Another advancement in IVF technology is the use of time-lapse imaging. Time-lapse imaging allows embryologists to monitor the development of embryos in real time, providing more detailed information about their viability and quality.

In addition to these advances, IVF clinics are now offering a range of services, including egg freezing, sperm banking, and surrogacy. These services provide more options for couples struggling with infertility and have contributed to the growth of the IVF market.

Shift Towards Delayed Childbirth

The shift towards delayed childbirth is another factor responsible for the growth of the global market of in-vitro fertilization (IVF) in the forecast period. With changing social and economic factors, people are choosing to delay having children until later in life. This delay in childbearing has been associated with an increased risk of infertility due to age-related factors, such as decreased ovarian reserve and an increased incidence of conditions like endometriosis.

As more people choose to delay having children, the demand for IVF services is expected to increase. IVF has become a viable option for couples who are struggling with infertility due to age-related factors. IVF treatment can help women to conceive using their own eggs, even if their ovarian reserve has declined. This means that women who are past their natural fertility window can conceive.

Moreover, the advancements in IVF technology, including improved embryo culture and cryopreservation techniques, have increased the chances of successful conception using IVF treatment. These advancements have resulted in higher success rates and lower costs, making IVF more accessible and affordable for couples who are looking to conceive.

The shift towards delayed childbirth is expected to drive the growth of the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where the trend towards delayed childbirth is most pronounced. In these countries, IVF treatment has become an increasingly popular option for couples who are struggling with infertility due to age-related factors.

The shift towards delayed childbirth is expected to be a key driver of the global market for in vitro fertilization in the forecast period. As more people delay having children, the demand for IVF services is expected to increase, particularly in developed countries where the trend is most pronounced.

Market Segmentation

Global In-Vitro Fertilization Market can be segmented based on technique, product, egg donor, infertility, application, and region. Based on technique, the market can be divided into ICSI IVF and non-ICSI/ traditional IVF. Based on product, the market is divided into IVF culture media, ICSI machines, IVF incubators, cryo-system, and others. Based on egg donors, the market is divided into frozen non-donor, fresh non-donor, frozen donors, and fresh donors. Based on infertility, the market can be divided into male and female. Based on application, the market is divided into fertility clinics, hospitals, and others. Regionally, the In-Vitro Fertilization Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

The Fertility Center of Las Vegas, Overlake Reproductive Health, Gennet City Fertility, Zita West Clinic, Fertility Plus Clinic, Nova IVF Centre and Fertility Clinic, Bloom IVF Centre, Progenesis Fertility Center, Medicana IVF Center, Medical Park Hospitals, ART Fertility Clinics, Millennium Medical Center (MMC) IVF Fertility Center, Tambre Fertility Clinic, Medical Park Hospitals, Hisar Hospital among others are the leading players operating in the Global In-Vitro Fertilization Market.

Report Scope:

In this report, Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

  • ICSI IVF
  • Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

  • IVF Culture Media
  • ICSI Machine
  • IVF Incubators
  • Cryo-System
  • Others

In-Vitro Fertilization Market, By Egg Donor:

  • Frozen Non-donor
  • Fresh Non-donor
  • Frozen Donor
  • Fresh Donor

In-Vitro Fertilization Market, By Infertility:

  • Male
  • Female

In-Vitro Fertilization Market, By Application:

  • Fertility Clinics
  • Hospitals
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global In-Vitro Fertilization Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
    • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
    • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
    • 5.2.4. By Infertility (Male v/s Female)
    • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Product
    • 6.2.3. By Egg Donor
    • 6.2.4. By Infertility
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-Vitro Fertilization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Egg Donor
        • 6.3.1.2.4. By Infertility
        • 6.3.1.2.5. By Application
    • 6.3.2. Canada In-Vitro Fertilization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Egg Donor
        • 6.3.2.2.4. By Infertility
        • 6.3.2.2.5. By Application
    • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Egg Donor
        • 6.3.3.2.4. By Infertility
        • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Product
    • 7.2.3. By Egg Donor
    • 7.2.4. By Infertility
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-Vitro Fertilization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Egg Donor
        • 7.3.1.2.4. By Infertility
        • 7.3.1.2.5. By Application
    • 7.3.2. Germany In-Vitro Fertilization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Egg Donor
        • 7.3.2.2.4. By Infertility
        • 7.3.2.2.5. By Application
    • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Egg Donor
        • 7.3.3.2.4. By Infertility
        • 7.3.3.2.5. By Application
    • 7.3.4. Italy In-Vitro Fertilization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Egg Donor
        • 7.3.4.2.4. By Infertility
        • 7.3.4.2.5. By Application
    • 7.3.5. Spain In-Vitro Fertilization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Egg Donor
        • 7.3.5.2.4. By Infertility
        • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Product
    • 8.2.3. By Egg Donor
    • 8.2.4. By Infertility
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-Vitro Fertilization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Egg Donor
        • 8.3.1.2.4. By Infertility
        • 8.3.1.2.5. By Application
    • 8.3.2. India In-Vitro Fertilization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Egg Donor
        • 8.3.2.2.4. By Infertility
        • 8.3.2.2.5. By Application
    • 8.3.3. Japan In-Vitro Fertilization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Egg Donor
        • 8.3.3.2.4. By Infertility
        • 8.3.3.2.5. By Application
    • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Egg Donor
        • 8.3.4.2.4. By Infertility
        • 8.3.4.2.5. By Application
    • 8.3.5. Australia In-Vitro Fertilization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Egg Donor
        • 8.3.5.2.4. By Infertility
        • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Product
    • 9.2.3. By Egg Donor
    • 9.2.4. By Infertility
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Egg Donor
        • 9.3.1.2.4. By Infertility
        • 9.3.1.2.5. By Application
    • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Egg Donor
        • 9.3.2.2.4. By Infertility
        • 9.3.2.2.5. By Application
    • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Egg Donor
        • 9.3.3.2.4. By Infertility
        • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Product
    • 10.2.3. By Egg Donor
    • 10.2.4. By Infertility
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Egg Donor
        • 10.3.1.2.4. By Infertility
        • 10.3.1.2.5. By Application
    • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Egg Donor
        • 10.3.2.2.4. By Infertility
        • 10.3.2.2.5. By Application
    • 10.3.3. UAE In-Vitro Fertilization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Egg Donor
        • 10.3.3.2.4. By Infertility
        • 10.3.3.2.5. By Application
    • 10.3.4. Turkey In-Vitro Fertilization Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technique
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Egg Donor
        • 10.3.4.2.4. By Infertility
        • 10.3.4.2.5. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
    • 15.4.1. The Fertility Center of Las Vegas
    • 15.4.2. Overlake Reproductive Health
    • 15.4.3. Gennet City Fertility
    • 15.4.4. Zita West Clinic
    • 15.4.5. Fertility Plus Clinic
    • 15.4.6. Nova IVF Centre and Fertility Clinic
    • 15.4.7. Bloom IVF Centre
    • 15.4.8. Progenesis Fertility Center
    • 15.4.9. Medicana IVF Center
    • 15.4.10. Medical Park Hospitals
    • 15.4.11. ART Fertility Clinics
    • 15.4.12. Millennium Medical Center (MMC) IVF Fertility Center
    • 15.4.13. Tambre Fertility Clinic
    • 15.4.14. Medical Park Hospitals
    • 15.4.15. Hisar Hospital

16. Strategic Recommendations